Cargando…

Prognostic Value of Myeloid Differentiation Primary Response 88 and Toll-Like Receptor 4 in Breast Cancer Patients

PURPOSE: Breast cancer remains a major cause of death in women worldwide, and tumor metastasis is the leading cause of death in breast cancer patients after conventional treatment. Chronic inflammation is often related to the occurrence and growth of various malignancies. This study evaluated the pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Fang-Jing, Liu, Zhe-Bin, Hu, Xin, Ling, Hong, Li, Shan, Wu, Jiong, Shao, Zhi-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216121/ https://www.ncbi.nlm.nih.gov/pubmed/25360699 http://dx.doi.org/10.1371/journal.pone.0111639

Ejemplares similares

Toll-like receptor 4 and myeloid differentiation factor 88 are required for gastric bypass-induced metabolic effects
por: Haija, Marwa Abu El, et al.
Publicado: (2021)

TcpC inhibits toll-like receptor signaling pathway by serving as an E3 ubiquitin ligase that promotes degradation of myeloid differentiation factor 88
por: Fang, Jia-qi, et al.
Publicado: (2021)

High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer
por: Wang, E L, et al.
Publicado: (2010)

Protein overexpression of toll-like receptor 4 and myeloid differentiation factor 88 in oral squamous cell carcinoma and clinical significance
por: Li, Lili, et al.
Publicado: (2021)

Toll-Like Receptor 4–Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Shikonin Treatment of CIA by Regulating Treg/Th17 Expression
por: Dai, Qiaomei, et al.
Publicado: (2018)

Myeloid Differentiation Primary Response 88–Cyclin D1 Signaling in Breast Cancer Cells Regulates Toll-Like Receptor 3-Mediated Cell Proliferation
por: Singh, Aradhana, et al.
Publicado: (2020)

Hypoxia-Inducible Ubiquitin Specific Peptidase 13 Contributes to Tumor Growth and Metastasis via Enhancing the Toll-Like Receptor 4/Myeloid Differentiation Primary Response Gene 88/Nuclear Factor-κB Pathway in Hepatocellular Carcinoma
por: Gao, Shan, et al.
Publicado: (2020)

Corrigendum to “Toll-Like Receptor 4–Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Shikonin Treatment of CIA by Regulating Treg/Th17 Expression”
por: Dai, Qiaomei, et al.
Publicado: (2019)

Identification and Function of Myeloid Differentiation Factor 88 (MyD88) in Litopenaeus vannamei
por: Zhang, Shuang, et al.
Publicado: (2012)

Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation
por: Wang, James Q., et al.
Publicado: (2014)

Allicin Improves Lung Injury Induced by Sepsis via Regulation of the Toll-Like Receptor 4 (TLR4)/Myeloid Differentiation Primary Response 88 (MYD88)/Nuclear Factor kappa B (NF-κB) Pathway
por: Shen, Ning, et al.
Publicado: (2019)

Protective Effect of Hesperidin Against Sepsis-Induced Lung Injury by Inducing the Heat-Stable Protein 70 (Hsp70)/Toll-Like Receptor 4 (TLR4)/ Myeloid Differentiation Primary Response 88 (MyD88) Pathway
por: Yuan, Xiaoyan, et al.
Publicado: (2019)

Prognostic values of myeloid differentiation factor 88 (MYD88) and transducin (β)-like receptor 1 (TBLR1) expression in tissues of diffuse large B-cell non-Hodgkin lymphoma patients – an immunohistochemical study
por: Mohamed, Asmaa Hussein, et al.
Publicado: (2022)

Toll-Like Receptor 4–Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Inflammatory Development of Polymyositis by Mediating Interferon-γ and Interleukin-17A in Humans and Experimental Autoimmune Myositis Mouse Model
por: Zhang, Hongya, et al.
Publicado: (2017)

Wumei pills attenuates 5-fluorouracil-induced intestinal mucositis through Toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-κB pathway and microbiota regulation
por: Lu, Dong-Xue, et al.
Publicado: (2022)

Beyond MyD88 and TRIF Pathways in Toll-Like Receptor Signaling
por: Piras, Vincent, et al.
Publicado: (2014)

SPOP negatively regulates Toll-like receptor-induced inflammation by disrupting MyD88 self-association
por: Hu, Yun-Hong, et al.
Publicado: (2020)

Treatment Effect of Mometasone Furoate Cream on Lichen Sclerosus et Atrophicus of External Genitalia in Boys and Its Correlation with Toll-Like Receptor 4 and Myeloid Differentiation Factor 88
por: Sun, Hong, et al.
Publicado: (2022)

Myeloid Differentiation Factor 88 (MyD88)-Deficiency Increases Risk of Diabetes in Mice
por: Hosoi, Toru, et al.
Publicado: (2010)

Cyclin-dependent kinase 5 negatively regulates antiviral immune response by disrupting myeloid differentiation primary response protein 88 self-association
por: Ren, Jian-Ping, et al.
Publicado: (2023)

MyD88-dependent Toll-like receptor 4 signal pathway in intervertebral disc degeneration
por: Qin, Chuqiang, et al.
Publicado: (2016)

Retracted: Treatment Effect of Mometasone Furoate Cream on Lichen Sclerosus et Atrophicus of External Genitalia in Boys and Its Correlation with Toll-Like Receptor 4 and Myeloid Differentiation Factor 88
por: Engineering, Journal of Healthcare
Publicado: (2023)

Myeloid differentiation primary response protein 88 (MyD88)-deficient dendritic cells exhibit a skewed cytokine response to BCG
por: Kumar, Pawan, et al.
Publicado: (2019)

miR-139-5p protects septic mice with acute lung injury by inhibiting Toll-like receptor 4/Myeloid differentiation factor 88/Nuclear factor-&mac_kgr;B signaling pathway
por: Zhang, Xiuxiu, et al.
Publicado: (2021)

Leaky Gut Plays a Critical Role in the Pathophysiology of Autism in Mice by Activating the Lipopolysaccharide-Mediated Toll-Like Receptor 4–Myeloid Differentiation Factor 88–Nuclear Factor Kappa B Signaling Pathway
por: Li, Fang, et al.
Publicado: (2022)

Investigation of the relationship between community-acquired respiratory distress syndrome toxin and the high-mobility group box protein 1-toll-like receptors-myeloid differentiation factor 88 signaling pathway in Mycoplasma pneumoniae pneumonia
por: Fan, Yujie, et al.
Publicado: (2022)

Myeloid differentiation primary response gene (MyD) 88 signalling is not essential for intestinal fibrosis development
por: Lutz, C., et al.
Publicado: (2017)

CCL-34, a synthetic toll-like receptor 4 activator, modulates differentiation and maturation of myeloid dendritic cells
por: Fu, Shu-Ling, et al.
Publicado: (2016)

Overexpression of the Toll-Like Receptor (TLR) Signaling Adaptor MYD88, but Lack of Genetic Mutation, in Myelodysplastic Syndromes
por: Dimicoli, Sophie, et al.
Publicado: (2013)

Myeloid differentiation factor 88 is required for resistance to Neospora caninum infection
por: Mineo, Tiago W.P., et al.
Publicado: (2009)

An analysis of the expression and function of myeloid differentiation factor 88 in human osteosarcoma
por: Chen, Jun, et al.
Publicado: (2018)

Imiquimod Targets Toxoplasmosis Through Modulating Host Toll-Like Receptor-MyD88 Signaling
por: Hamie, Maguy, et al.
Publicado: (2021)

MyD88-dependent signaling drives toll-like receptor-induced trained immunity in macrophages
por: Owen, Allison M., et al.
Publicado: (2022)

Toll-Like Receptors, Associated Biological Roles, and Signaling Networks in Non-Mammals
por: Nie, Li, et al.
Publicado: (2018)

Role of Adaptor Protein Myeloid Differentiation 88 (MyD88) in Post-Subarachnoid Hemorrhage Inflammation: A Systematic Review
por: Ahmed, Hammad, et al.
Publicado: (2021)

The Toll-Like Receptor Signaling Molecule Myd88 Contributes to Pancreatic Beta-Cell Homeostasis in Response to Injury
por: Bollyky, Paul L., et al.
Publicado: (2009)

MyD88 Death-Domain Oligomerization Determines Myddosome Architecture: Implications for Toll-like Receptor Signaling
por: Moncrieffe, Martin C., et al.
Publicado: (2020)

Extract from Mulberry (Morus australis) leaf decelerate acetaminophen induced hepatic inflammation involving downregulation of myeloid differentiation factor 88 (MyD88) signals
por: Horng, Chi-Ting, et al.
Publicado: (2016)

The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy
por: Nurmi, Anna Maria, et al.
Publicado: (2022)

DOCK8 functions as an adaptor that links Toll-like receptor–MyD88 signaling to B cell activation
por: Jabara, Haifa H., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4f2d1n7htbqscd5dm6o2n1hjq2